|
|
Local breast density assessment using reacquired mammographic images |
GarcÃa Marcos, Eloy
; Diaz Montesdeoca, Oliver
; Martà Marly, Robert
; DÃez Donoso, Santiago
; Gubern Mérida, Albert
; SentÃs, Melcior
; Martà BonmatÃ, Joan
; Oliver i Malagelada, Arnau
|
|
|
Local breast density assessment using reacquired mammographic images |
GarcÃa Marcos, Eloy
; Diaz Montesdeoca, Oliver
; Martà Marly, Robert
; DÃez Donoso, Santiago
; Gubern Mérida, Albert
; SentÃs, Melcior
; Martà BonmatÃ, Joan
; Oliver i Malagelada, Arnau
|
|
1 agost 2017 |
Local breast density assessment using reacquired mammographic images |
GarcÃa Marcos, Eloy
; Diaz Montesdeoca, Oliver
; Martà Marly, Robert
; Diez, Yago
; Gubern Mérida, Albert
; SentÃs, Melcior
; Martà BonmatÃ, Joan
; Oliver i Malagelada, Arnau
|
|
abril 2012 |
Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts |
Cufà González, SÃlvia
; Corominas Faja, Bruna
; Vázquez MartÃn, Alejandro
; Oliveras Ferrarós, Cristina
; Dorca Ribugent, Joan
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Menéndez Menéndez, Javier Abel
|
|
|
Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts |
Cufà González, SÃlvia
; Corominas Faja, Bruna
; Vázquez MartÃn, Alejandro
; Oliveras Ferrarós, Cristina
; Dorca Ribugent, Joan
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Menéndez Menéndez, Javier Abel
|
|
|
Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts |
Cufà González, SÃlvia
; Corominas Faja, Bruna
; Vázquez MartÃn, Alejandro
; Oliveras Ferrarós, Cristina
; Dorca Ribugent, Joan
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Menéndez Menéndez, Javier Abel
|
|
1 juny 2018 |
Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts |
|
|
5 juny 2018 |
Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts |
Cufà González, SÃlvia
; Corominas Faja, Bruna
; Vázquez MartÃn, Alejandro
; Oliveras Ferrarós, Cristina
; Dorca Ribugent, Joan
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Menéndez Menéndez, Javier Abel
|
|
2021 |
Necessitats de les dones amb cà ncer de mama finalitzada la fase aguda del tractament: projecte de recerca qualitatiu |
Garcia Canovas, Marta
|
|
setembre 2016 |
Un nou inhibidor sintètic de la sintasa d’à cids grassos (FASN) amb efectes citotòxics |
Polonio Alcalá, Emma
|
|
|
Un nou inhibidor sintètic de la sintasa d’à cids grassos (FASN) amb efectes citotòxics |
Polonio Alcalá, Emma
|
|
2011 |
A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines |
Puig i Miquel, Teresa
; Aguilar, Helena
; Cufà González, SÃlvia
; Oliveras, Glòria
; Turrado, Carlos
; Ortega Gutiérrez, SÃlvia
; Benhamú, Bellinda
; López RodrÃguez, Maria Luz
; Urruticoechea, Ander
; Colomer, Ramon
|
|
|
A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines |
Puig i Miquel, Teresa
; Aguilar, Helena
; Cufà González, SÃlvia
; Oliveras, Glòria
; Turrado, Carlos
; Ortega Gutiérrez, SÃlvia
; Benhamú, Bellinda
; López RodrÃguez, Maria Luz
; Urruticoechea, Ander
; Colomer, Ramon
|
|
|
A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines |
Puig i Miquel, Teresa
; Aguilar, Helena
; Cufà González, SÃlvia
; Oliveras, Glòria
; Turrado, Carlos
; Ortega Gutiérrez, SÃlvia
; Benhamú, Bellinda
; López RodrÃguez, Maria Luz
; Urruticoechea, Ander
; Colomer, Ramon
|
|
1 juny 2018 |
A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines |
|
|
5 juny 2018 |
A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines |
Puig i Miquel, Teresa
; Aguilar, Helena
; Cufà González, SÃlvia
; Oliveras, Glòria
; Turrado, Carlos
; Ortega Gutiérrez, SÃlvia
; Benhamú, Bellinda
; López RodrÃguez, Maria Luz
; Urruticoechea, Ander
; Colomer, Ramon
|
|
gener 2016 |
Pathological assessment of the margin status to reduce the recurrence rate in women with DCIS of the breast |
Balot Fernández, Natalia
|
|
|
Pathological assessment of the margin status to reduce the recurrence rate in women with DCIS of the breast |
Balot Fernández, Natalia
|
|
|
Preclinical evaluation of fatty acid synthase and egfrinhibition in triple-negative breast cancer |
Giró Perafita, Ariadna
; Palomeras, Sònia
; Lum, David H.
; Blancafort, Adriana
; Viñas, Gemma
; Oliveras, Glòria
; Perez Bueno, Ferran
; Sarrats Carbó, Ariadna
; Welm, Alana L.
; Puig i Miquel, Teresa
|
|
|
Preclinical evaluation of fatty acid synthase and egfrinhibition in triple-negative breast cancer |
Giró Perafita, Ariadna
; Palomeras, Sònia
; Lum, David H.
; Blancafort, Adriana
; Viñas, Gemma
; Oliveras, Glòria
; Perez Bueno, Ferran
; Sarrats Carbó, Ariadna
; Welm, Alana L.
; Puig i Miquel, Teresa
|
|
1 juny 2018 |
Preclinical evaluation of fatty acid synthase and egfrinhibition in triple-negative breast cancer |
|
|
5 juny 2018 |
Preclinical evaluation of fatty acid synthase and egfrinhibition in triple-negative breast cancer |
Giró Perafita, Ariadna
; Palomeras, Sònia
; Lum, David H.
; Blancafort, Adriana
; Viñas, Gemma
; Oliveras, Glòria
; Perez Bueno, Ferran
; Sarrats Carbó, Ariadna
; Welm, Alana L.
; Puig i Miquel, Teresa
|
|
15 setembre 2016 |
Preclinical evaluation of fatty acid synthase and egfrinhibition in triple-negative breast cancer |
Giró Perafita, Ariadna
; Palomeras Pairet, Sònia
; Lum, David H.
; Blancafort, Adriana
; Viñas, Gemma
; Oliveras, Glòria
; Perez Bueno, Ferran
; Sarrats Carbó, Ariadna
; Welm, Alana L.
; Puig i Miquel, Teresa
|
|
novembre 2021 |
Prophylactic external radiotherapy versus screening strategy in women with BRCA 1/2 mutation: a multicenter, randomized, open-labelled clinical trial |
Baltà Salvador, Jana
|
|
|
Rapid increase in incidence of breast ductal cancer in situ in Girona, Spain 1983-2007 |
Puig-Vives, Montserrat
; Pollán SantamarÃa, Marina
; Rué, Montserrat
; Osca-Gelis, Gemma
; Izquierdo, A.
; Marcos-Gragera, Rafael
|